Table 1.
Co‐culture settings | |||||
---|---|---|---|---|---|
Matrix | Device (methods) | Cell types | Application | Technology | Ref |
DOUBLE CULTURES, Cancer cells and fibroblasts | |||||
Collagen I | Transwell with mouse intestinal basal membrane. Lower compartment, fibroblast mixed in collagen; upper compartment, tumor cells | HT29, HCT116; patient derived CAFs and NFs | Invasion studies | IF; microscopy methods; time‐lapse imaging | [155] |
BME; Matrigel | Transwell. Lower compartment, fibroblasts seeded directly or embedded in BME; upper compartment, organoids in matrigel droplets | Mouse and human CRC organoids; primary mouse colon fibroblasts | Tumor‐stroma interaction studies | qRT‐PCR analysis; contraction assay | [156] |
Matrigel | Transwell. Lower compartment, fibroblasts; upper compartment, organoids in matrigel droplets |
PDO and CAFs from surgical specimens of CRCs |
Gene expression profiles | DNA microarray; viability assays | [165] |
Collagen | Tumoroids in two layers of collagen gel | DLD‐1; human primary lung cancer‐derived fibroblasts | Invasion studies | Fluorescence imaging; IHC; time‐lapse experiments | [150] |
Tumoroids formed in agarose coated plates | SW480; MRC5 | Drug response analysis; secretomes analysis | Fluorescence imaging; LC‐MS; viability assays | [157] | |
Tumoroids formed in polydimethylsiloxane (PDMS) microwell platform. | HCT‐8; NIH3T3 | Drug response analysis; co‐culture self‐organization; stiffness variation | Immunostaining; time‐laps imaging; mechanical stability measurement; WB analysis | [158] | |
Tumoroids formed in hanging drop plates | HCT116; CCD‐18Co | High‐content drug discovery | Genomics screening; Imaging analysis; RNAseq | [168] | |
BME; Matrigel | Matrix droplet, Tumor cells and CAFs plated together. Transwell. Lower compartment, fibroblasts embedded in BME; upper compartment, organoids in matrigel droplets | PDO and CAFs from surgical specimens of CRCs | Tumor‐stroma interaction studies; drug response analysis | qRT‐PCR analysis; RNAseq; viability assays; | [163] |
Collagen I | Matrix droplet into a force sensor | FET; human primary colorectal CAFs | Cell forces and tissue stiffness measurement | High‐resolution force sensor | [154] |
Matrigel; Collagen I | Organoids plated in Matrix droplet and CAFs in suspension in the well |
PDO and CAFs from surgical specimens of CRC liver metastasis |
Tumor‐stroma interaction studies; mesenchymal‐like cancer model | scRNAseq; IF; live cell imaging; cell culture medium assays | [161] |
hyaluronan‐gelatin hydrogels | CAFs seeded on top of each PDO Matrix droplet | PDO and CAFs from surgical specimens of CRCs | Drug response analysis; gene expression profiles | RNAseq; viability assays; immunostaining | [164] |
Matrigel; Collagen I | Tumor cells and fibroblasts plated together in Matrix droplet or divided into individual layers in ALI culture. | PDO, NFs and CAFs from surgical specimens of CRCs | Tumor‐stroma interaction studies | Immunostaining; RNAseq; Proteomic; 3D migration assay; Cytokine array | [162] |
GelMA | Bioprinting, PDO and CAF microtissue formed by acoustic droplets technology | PDO and CAFs from surgical specimens of CRCs | Migration and invasion models; drug response analysis | Time‐lapse imaging; IF | [167] |